Peripheral Blood: Clinical Trials

13 trials of Peripheral Blood, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 active not recruiting, 3 recruiting, 1 terminated. 13 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 5, Active not recruiting 4, Recruiting 3, Terminated 1
Phase 13Completed 1, Recruiting 1, Terminated 1

Follow Peripheral Blood: new trials by email Literature Review of Peripheral Blood trials Research Report on Peripheral Blood

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia
Phase 2RecruitingCity of Hope Medical Center352026-11-052026-10-08
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Bendamustine, Pralatrexate, Bone Marrow Aspiration - Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center502026-04-272026-05-11
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia
Phase 2Active not recruitingFred Hutchinson Cancer Center12025-09-252026-05-22
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
Cyclophosphamide, Itacitinib, Peripheral Blood Stem Cell Transplantation - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2Active not recruitingCity of Hope Medical Center202022-12-292026-10-14
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2RecruitingChildren's Oncology Group1602021-07-132026-09-23
A Study of N-acetylcysteine in Patients With COVID-19 Infection
N-acetylcysteine, Peripheral Blood - Covid-19
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center482020-05-012026-05-01
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
Abemaciclib, Nivolumab, Tumor biopsy - Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2TerminatedWashington University School of Medicine62019-05-292020-12-03
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Bendamustine, Rituximab, Acalabrutinib - Mantle Cell Lymphoma
Phase 2CompletedWashington University School of Medicine132018-11-292026-04-21
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
BMS-813160, Nivolumab, Gemcitabine - Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2CompletedWashington University School of Medicine402018-08-312025-07-29
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation, Busulfan, Gemcitabine Hydrochloride - Plasma Cell Leukemia, Plasmacytoma
Phase 2CompletedM.D. Anderson Cancer Center832015-09-142025-03-18
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
MK-3475 (neoadjuvant), Surgery, Intensity modulated radiation therapy - Cancer of Head and Neck, Head and Neck Cancer
Phase 2CompletedWashington University School of Medicine672015-03-252026-08-05
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Fludarabine phosphate, Busulfan, Total-Body Irradiation - Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University622012-12-242025-10-30
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia
Phase 2Active not recruitingNational Cancer Institute (NCI)972009-09-012026-11-18

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Myelodysplastic Syndromes (3)  ·  Anemia, Aplastic (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Multiple Myeloma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Primary Myelofibrosis (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Burkitt Lymphoma (1)  ·  COVID-19 (1)  ·  Carcinoma, Embryonal (1)  ·  Choriocarcinoma (1)  ·  Head and Neck Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

Washington University School of Medicine (4)  ·  City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Children's Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (13)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)

Top investigators

Douglas R Adkins, M.D. (2)  ·  Monzr M Al Malki (2)  ·  Brad S Kahl, M.D. (1)  ·  Dolores Grosso, RN, CRNP, DNP (1)  ·  Farhad Ravandi-Kashani (1)  ·  Kian-Huat Lim, M.D., Ph.D. (1)  ·  Lorenzo Iovino, MD, PhD (1)  ·  Neal Flomenberg, MD (1)  ·  Rachel B. Salit, MD (1)  ·  Santosha Vardhana, MD, PhD (1)  ·  Shannon M MacDonald (1)  ·  Yago L Nieto (1)

Results publications

PMID 29618479, PMID 32665297

NIH funding

P30CA033572 (2), P50CA196510 (1), U10CA032102 (1), U10CA180886 (1), U10CA180888 (1)